ES2073277T3 - Sustancias de naturaleza polipeptida utiles en la terapia humana. - Google Patents

Sustancias de naturaleza polipeptida utiles en la terapia humana.

Info

Publication number
ES2073277T3
ES2073277T3 ES92900285T ES92900285T ES2073277T3 ES 2073277 T3 ES2073277 T3 ES 2073277T3 ES 92900285 T ES92900285 T ES 92900285T ES 92900285 T ES92900285 T ES 92900285T ES 2073277 T3 ES2073277 T3 ES 2073277T3
Authority
ES
Spain
Prior art keywords
venues
substances
human therapy
useful polypeptide
induce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92900285T
Other languages
English (en)
Inventor
Alberto Bartorelli
Angela Turiano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zetesis SpA
Original Assignee
Zetesis SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis SpA filed Critical Zetesis SpA
Application granted granted Critical
Publication of ES2073277T3 publication Critical patent/ES2073277T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SUSTANCIAS DE POLIPEPTIDA NATURAL OBTENIBLE POR EXTRACCION DE TEJIDOS HOMOGENEOS ANIMALES, CUYAS SUSTANCIAS PUEDEN INDUCIR, CUANDO SE ADMINISTRAN A VARIAS ESPECIES ANIMALES, LA FORMACION DE ANTICUERPOS VALIDOS PARA RECONOCER EN VIVO O EN VITRO ANTIGENOS, LOS CUALES ESTAN PRESENTES EN CELULAS TUMORALES HUMANAS; Y PUEDEN REDUCIR O INHIBIR EL DOLOR, INDUCIR UN EFECTO DE LISIS CELULAR, E INHIBIR O REDUCIR EL CRECIMIENTO DEL TUMOR, CUANDO SE ADMINISTRA A HUMANOS AFECTADOS POR TUMORES MALIGNOS DE DIFERENTES CLASES.
ES92900285T 1990-12-11 1991-12-09 Sustancias de naturaleza polipeptida utiles en la terapia humana. Expired - Lifetime ES2073277T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02234190A IT1244879B (it) 1990-12-11 1990-12-11 Estratti da tessuti animali, utili in terapia e in diagnostica.

Publications (1)

Publication Number Publication Date
ES2073277T3 true ES2073277T3 (es) 1995-08-01

Family

ID=11194931

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92900285T Expired - Lifetime ES2073277T3 (es) 1990-12-11 1991-12-09 Sustancias de naturaleza polipeptida utiles en la terapia humana.

Country Status (16)

Country Link
US (1) US5824640A (es)
EP (1) EP0574394B1 (es)
JP (1) JP3213942B2 (es)
KR (1) KR100196028B1 (es)
AT (1) ATE122890T1 (es)
AU (1) AU661287B2 (es)
CA (1) CA2098113C (es)
CZ (1) CZ283037B6 (es)
DE (1) DE69110060T2 (es)
DK (1) DK0574394T3 (es)
ES (1) ES2073277T3 (es)
HU (1) HU217615B (es)
IT (1) IT1244879B (es)
NO (1) NO308396B1 (es)
RU (1) RU2113224C1 (es)
WO (1) WO1992010197A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27048C2 (uk) * 1993-10-18 2000-02-28 Центр Ембріональних Тканин "Емселл" Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IT1276860B1 (it) * 1994-11-04 1997-11-03 Zetesis Spa Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
IT1276707B1 (it) * 1995-06-13 1997-11-03 Zetesis Spa Composizioni farmaceutiche ad attivita' analgesica
IT1282608B1 (it) 1996-02-13 1998-03-31 Zetesis Spa Sequenza oligonocleotidica da fegato di capra
IT1284524B1 (it) * 1996-09-13 1998-05-21 Zetesis Spa Uso di proteine come agenti anti-retrovirali
DE69719525T2 (de) * 1996-09-18 2003-10-02 Zetesis S.P.A., Mailand/Milano Verwendung von proteine als mittel gegen autoimmunekrankheiten
IT1298442B1 (it) * 1998-02-24 2000-01-10 Zetesis Spa Composizioni orali a basso dosaggio di proteine citotossiche
US20030153511A1 (en) * 2000-06-08 2003-08-14 Alberto Panerai Method of treatment of huntington's chorea with a protein extractable from mammalian organs
US20030165492A1 (en) * 2000-06-08 2003-09-04 Alberto Panerai Method of treatment of alzheimer's disease with a protein extractable from mammalian organs
MXPA02012092A (es) * 2000-06-08 2004-08-19 Rakepoll Holding B V Metodo de tratamiento de la enfermedad de parkinson con una proteina extraible de organos.
EP1286683A2 (en) * 2000-06-08 2003-03-05 Rakepoll Holding B.V. A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
ITMI20022307A1 (it) * 2002-10-30 2004-04-30 Zetesis Spa Associazioni anti-tumorali comprendenti proteine e chemioterapici.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
WO1985003003A1 (en) * 1984-01-12 1985-07-18 Volker Rusch Biologically active substance with hormonal properties, production process thereof and utilization of histones for medical purposes
JPH064675B2 (ja) * 1985-07-29 1994-01-19 伝一 水野 抗腫瘍性ポリペプチド

Also Published As

Publication number Publication date
EP0574394A1 (en) 1993-12-22
CA2098113C (en) 2002-02-05
IT9022341A1 (it) 1992-06-11
DE69110060T2 (de) 1995-09-28
NO932101D0 (no) 1993-06-09
WO1992010197A1 (en) 1992-06-25
AU661287B2 (en) 1995-07-20
KR100196028B1 (ko) 1999-06-15
NO932101L (no) 1993-08-10
JPH06504039A (ja) 1994-05-12
HU217615B (hu) 2000-03-28
EP0574394B1 (en) 1995-05-24
CZ283037B6 (cs) 1997-12-17
HU9301677D0 (en) 1993-09-28
DK0574394T3 (da) 1995-10-16
RU2113224C1 (ru) 1998-06-20
AU9035791A (en) 1992-07-08
DE69110060D1 (de) 1995-06-29
NO308396B1 (no) 2000-09-11
IT9022341A0 (it) 1990-12-11
CZ111693A3 (en) 1994-04-13
JP3213942B2 (ja) 2001-10-02
HUT64569A (en) 1994-01-28
ATE122890T1 (de) 1995-06-15
CA2098113A1 (en) 1992-06-11
US5824640A (en) 1998-10-20
IT1244879B (it) 1994-09-12

Similar Documents

Publication Publication Date Title
ES2073277T3 (es) Sustancias de naturaleza polipeptida utiles en la terapia humana.
Lee et al. Sunlight and the aetiology of malignant melanoma: a synthesis
NO175616C (no) Blanding for stimulering av hårvekst
ES2075019T3 (es) Anticuerpos monoclonales especificos del receptor del factor de crecimiento de la epidermis humana y composiciones terapeuticas que los contienen.
IT1077901B (it) Stimolatore di tessuto vivente di tipo impiantabile
BR7504001A (pt) Artigos cirurgicos implantaveis,utilizaveis em cirurgia humana ou animal,total ou parcialmente bioresorbaveis
CY1105634T1 (el) Η χρηση του ραδιου -223 για τη στοχευση ασβεστωμενων ιστων για την ανακουφιση πονου και τη θεραπεια οστικου καρκινου
ATE113607T1 (de) Polypeptidverbindungen mit wachstumshormonfreisetzender aktivität.
RU93042874A (ru) Соединения полипептидной природы, способ их получения, композиция на их основе, их применение в противоопухолевой терапии
AR016254A1 (es) Una composicion de celulas de tumor modificadas con un hapteno o extracto de celulas tumorales y uso de la misma en la elaboracion de un medicamento.
Dinehart et al. Basal cell carcinoma in young patients after irradiation for childhood malignancy
ES2095846T3 (es) Composicion estable y liofilizada de un ester/eter de polihematoporfirina.
Veliath et al. Malignant Pilomatrixoma Report of a Case
Dougherty et al. Photoradiation therapy of malignant tumors; role of the laser
ES2000437T3 (es) Procedimiento para potenciar el crecimiento del parenquima mamario.
AR023726A1 (es) Terapia con gch para el tratamiento del cancer de mama
ES2080954T3 (es) Uso de beta-aletina en cultivos de celulas y en terapia.
谢大任 Treatment of Cancer
WO1996012019A3 (en) Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family
Brown et al. Connective tissue metabolism in swine. 1. Age related changes in levels of total and soluble hydroxyproline, elastin, hexosamine and non-collagen protein levels in the uterus and aorta during growth
HAYAKAWA Description of Haematopota shinonagai n. sp. from Honshu Island, Japan (Diptera, Tabanidae)
DE2701773A1 (de) Karzinom-heil-heizapparat
Macher et al. Melanoma: Clinical and Therapeutic Aspects
de Vos Necrospy data of eight reedbuck redunca arundinum from the Kruger National Park
Murayama et al. Prognostic Factors in 5-year Survivors of Esophageal Cancer Resection

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 574394

Country of ref document: ES